Cambridge Investment Research Advisors, Inc. Atai Life Sciences N.V. Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.4 Billion
- Q3 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Atai Life Sciences N.V. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 13,045 shares of ATAI stock, worth $14,871. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,045
Previous 13,674
4.6%
Holding current value
$14,871
Previous $18,000
16.67%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ATAI
# of Institutions
97Shares Held
12.8MCall Options Held
9.2KPut Options Held
118K-
Walleye Capital LLC Plymouth, MN2.76MShares$3.15 Million0.01% of portfolio
-
Morgan Stanley New York, NY2.72MShares$3.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.31MShares$1.49 Million0.0% of portfolio
-
Brown University719KShares$819,0890.39% of portfolio
-
Two Sigma Investments, LP New York, NY717KShares$817,5290.0% of portfolio
About ATAI Life Sciences N.V.
- Ticker ATAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 165,875,008
- Market Cap $189M
- Description
- Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...